Angiographic Evaluation of Coronary Microvascular Dysfunction in Patients with Heart Failure and Preserved Ejection Fraction

Microcirculation

Volumn 22, Issue 7, 2015, Pages 528-533

  Sucato, Vincenzo ^a   Evola, Salvatore ^a   Novo, Giuseppina ^a   Sansone, Angela ^a   Quagliana, Angelo ^a   Andolina, Giuseppe ^a   Assennato, Pasquale ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Coronary angiography; Echocardiography; Heart failure with preserved ejection fraction; Inflammation; Metabolic syndrome; Microvascular angina

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROCIRCULATION; MIDDLE AGED; PRIORITY JOURNAL; SYNDROME X; AGED; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; EVALUATION STUDY; HEART FAILURE; HEART STROKE VOLUME; PATHOPHYSIOLOGY; PERICARDIUM; RADIOGRAPHY;

AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PERICARDIUM; STROKE VOLUME;

EID: 84942104272     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/micc.12223     Document Type: Article

References (30)

1. Atmaca Y, Duzen V, Ozdol C, Altin T, Tulunay C, Ertas F, Erol C. Total blush score: a new index for the assessment of microvascular perfusion in idiopathic dilated cardiomyopathy. Coron Artery Dis 19: 181-185, 2008.
2. Atmaca Y, Ozdemir AO, Ozdol C, Oguz D, Gulec S, Kumbasar D, Erol C. Angiographic evaluation of myocardial perfusion in patients with syndrome X. Am J Cardiol 96: 803-805, 2005.
3. Borbély A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, Leite-Moreira AF, Bronzwaer JG, Papp Z, van der Velden J, Stienen GJ, Paulus WJ. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104: 780-786, 2009.
4. Borbély A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation 111: 774-781, 2005.
5. Bronzwaer JG, Paulus WJ. Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? Prog Cardiovasc Dis 47: 276-284, 2005.
6. Corrado E, Rizzo M, Aluigi L, Patti AM, Coppola G, Muratori I, Caccamo G, Balasus F, Novo S. Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. Int Angiol 31: 219-226, 2012.
7. Fazio G, Amoroso GR, Barbaro G, Novo G, Novo S. The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndrome. Curr Pharm Des 14: 2605-2612, 2008.
8. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method for assessing coronary artery flow. Circulation 93: 879-888, 1996.
9. Gonzalez A, Lopez B, Querejeta R, Zubillaga E, Echeverria T, Diez J. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension 55: 1418-1424, 2010.
10. Goodwill AG, Frisbee SJ, Stapleton PA, James ME, Frisbee JC. Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation 16: 667-684, 2009.
11. Granzier HL, Irving TC. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys J 68: 1027-1044, 1995.
12. Hermida N, Markl A, Hamelet J, Van Assche T, Vanderper A, Herijgers P, van Bilsen M, Hilfiker-Kleiner D, Noppe G, Beauloye C, Horman S, Balligand JL. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. Cardiovasc Res 99: 44-54, 2013.
13. Krentz AJ, Clough G, Byrne CD. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease? J Vasc Res 46: 515-526, 2009.
14. Lanza GA, Camici PG, Galiuto L, Niccoli G, Pizzi C, Di MA, Sestito A, Novo S, Piscione F, Tritto I, Ambrosio G, Bugiardini R, Crea F, Marzilli M; Gruppo di Studio di Fisiopatologia Coronarica e Microcircolazione, Società Italiana di Cardiologia. Methods to investigate coronary microvascular function in clinical practice. J Cardiovasc Med 14: 1-18, 2013.
15. Lebeche D, Davidoff AJ, Hajjar RJ. Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy. Nat Clin Pract Cardiovasc Med 5: 715-724, 2008.
16. Leung DY, Leung M. Non invasive/invasive imaging: significance and assessment of coronary microvascular dysfunction. Heart 97: 587-595, 2011.
17. LeWinter MM, Granzier H. Cardiac titin: a multifunctional giant. Circulation 121: 2137-2145, 2010.
18. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben LH, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33: 1787-1847, 2012.
19. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131: 550-559, 2015.
20. Novo S, Peritore A, Trovato RL, Guarneri FP, Di Lisi D, Muratori I, Novo G. Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up. Cardiovasc Diabetol 12: 155, 2013.
21. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62: 263-271, 2013.
22. Phan TT, Shivu GN, Abozguia K, Sanderson JE, Frenneaux M. The pathophysiology of heart failure with preserved ejection fraction: from molecular mechanisms to exercise haemodynamics. Int J Cardiol 158: 337-343, 2012.
23. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126: 65-75, 2012.
24. Sucato V, Novo G, Evola S, Novo S. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome. Int J Cardiol 186: 96-97, 2015.
25. Ulus T, Parspour A, Cavusoglu Y, Entok E, Uslu I, Demirustu C. Statins improve myocardial perfusion in metabolic syndrome patients who have perfusion defects on myocardial perfusion imaging and angiographically normal coronary arteries. Eur Rev Med Pharmacol 16: 328-334, 2012.
26. Van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbély A, van der Velden J, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117: 43-51, 2008.
27. Vanhecke TE, Kim R, Raheem SZ, McCullough PA. Myocardial ischemia in patients with diastolic dysfunction and heart failure. Curr Cardiol Rep 12: 216-222, 2010.
28. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 62: e147-e239, 2013.
29. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47: 76-84, 2006.
30. Zile MR, Richardson K, Cowles MK, Buckley JM, Koide M, Cowles BA, Gharpuray V, Cooper G 4th. Constitutive properties of adult mammalian cardiac muscle cells. Circulation 98: 567-579, 1998.